Therapeutic interventions for frail elderly patients: Part II: Ongoing and unpublished randomized trials

Progress in Cardiovascular Diseases

Volumn 57, Issue 2, 2014, Pages 144-151

  Bendayan, Melissa ^a   Bibas, Lior ^b,c   Levi, Michael ^b,c   Mullie, Louie ^b   Forman, Daniel E ^d,e   Afilalo, Jonathan ^b,c,f  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Frailty; Randomized clinical trials; Sarcopenia

Indexed keywords

ALLOPURINOL; BIMAGRUMAB; CALCIFEDIOL; GHRELIN; MILK PROTEIN; OMEGA 3 FATTY ACID; PLACEBO; SOYBEAN PROTEIN; TESTOSTERONE;

AGED; ANDROGEN THERAPY; ARTICLE; CALORIC RESTRICTION; DIET SUPPLEMENTATION; EXERCISE; FRAIL ELDERLY; HOME CARE; HOME MONITORING; HUMAN; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; SARCOPENIA; TAI CHI; TELEMONITORING; DAILY LIFE ACTIVITY; FRAILTY; KINESIOTHERAPY; METHODOLOGY; RANDOMIZED CLINICAL TRIALS; REVIEW; WALKING DIFFICULTY;

FRAILTY; RANDOMIZED CLINICAL TRIALS; SARCOPENIA;

ACTIVITIES OF DAILY LIVING; AGED; EXERCISE THERAPY; FRAIL ELDERLY; HUMANS; MOBILITY LIMITATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84909581980     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.07.005     Document Type: Article

References (20)

1. Clegg A., Young J., Iliffe S., Rikkert M.O., Rockwood K. Frailty in elderly people. Lancet 2013, 381(9868):752-762. 10.1016/S0140-6736(12)62167-9.
2. Frailty assessment in the cardiovascular care of older adults 2013, 10.1016/j.jacc.2013.09.070.
3. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014, 10.1016/j.jacc.2014.02.536.
4. Rolland Y., Dupuy C., Abellan van Kan G., Gillette S., Vellas B. Treatment strategies for sarcopenia and frailty. Med Clin North Am 2011, 95(3):427-438. [ix]. 10.1016/j.mcna.2011.02.008.
5. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56(3):M146-M156.
6. Cachexia versus sarcopenia 2011, 14(1):15-21. 10.1097/MCO.0b013e328340c2c2.
7. Peterson M.J., Giuliani C., Morey M.C., Pieper C.F., Evenson K.R., Mercer V., et al. Physical activity as a preventative factor for frailty: the health, aging, and body composition study. J Gerontol A Biol Sci Med Sci 2009, 64(1):61-68. 10.1093/gerona/gln001.
8. Latham N.K., Bennett D.A., Stretton C.M., Anderson C.S. Systematic review of progressive resistance strength training in older adults. J Gerontol A Biol Sci Med Sci 2004, 59(1):48-61.
9. Progressive resistance strength training for improving physical function in older adults. 2009;(3):CD002759. doi:10.1002/14651858.CD002759.pub2.
10. Liu C.K., Fielding R.A. Exercise as an intervention for frailty. Clin Geriatr Med 2011, 27(1):101-110. 10.1016/j.cger.2010.08.001.
11. Millward D.J. Nutrition and sarcopenia: evidence for an interaction. Proc Nutr Soc 2012, 71(4):566-575. 10.1017/S0029665112000201.
12. Fiatarone M.A., O'Neill E.F., Ryan N.D., Clements K.M., Solares G.R., Nelson M.E., et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994, 330(25):1769-1775. 10.1056/NEJM199406233302501.
13. Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment 2010, 58(9):1734-1738. 10.1111/j.1532-5415.2010.03016.x.
14. Androgen deficiency as a biological determinant of frailty: hope or hype? 2014, 62(6):1174-1178. 10.1111/jgs.12835.
15. Ottenbacher K.J., Ottenbacher M.E., Ottenbacher A.J., Acha A.A., Ostir G.V. Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc 2006, 54(11):1666-1673. 10.1111/j.1532-5415.2006.00938.x.
16. Toma M., McAlister F.A., Coglianese E.E., Vidi V., Vasaiwala S., Bakal J.A., et al. Testosterone supplementation in heart failure: a meta-analysis. Circ Heart Fail 2012, 5(3):315-321. 10.1161/CIRCHEARTFAILURE.111.965632.
17. Basaria S., Coviello A.D., Travison T.G., Storer T.W., Farwell W.R., Jette A.M., et al. Adverse events associated with testosterone administration. N Engl J Med 2010, 363(2):109-122. 10.1056/NEJMoa1000485.
18. Vigen R. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013, 310(17):1829. 10.1001/jama.2013.280386.
19. Hairi N.N., Cumming R.G., Naganathan V., Handelsman D.J., Le Couteur D.G., Creasey H., et al. Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc 2010, 58(11):2055-2062. 10.1111/j.1532-5415.2010.03145.x.
20. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People 2010, vol. 39:412-423. 10.1093/ageing/afq034.